
Keywords: PI، مهار کننده پروتئاز; HCV, hepatitis C virus; DAA, direct-acting antiviral; TPV, telaprevir; BOC, boceprevir; SMV, simeprevir; SOF, sofosbuvir; DSV, dasabuvir; LDV, ledipasvir; DCV, daclatasvir; OBV, ombitasvir; GT, genotype; RBV, ribavirin; PI, protease inhibitor; PTV/r, pari